{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:38:20Z","timestamp":1762216700500,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001279","name":"Orthopaedic Research and Education Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013464","name":"National Drug Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004343","name":"3M","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Orthopedic Clinics of North America"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ocl.2025.02.006","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T22:07:26Z","timestamp":1743890846000},"page":"259-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aspirin for Venous Thromboembolism Prophylaxis"],"prefix":"10.1016","volume":"56","author":[{"given":"Atthakorn","family":"Jarusriwanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham S.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Parvizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ocl.2025.02.006_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.arth.2019.08.049","article-title":"Have venous thromboembolism rates decreased in total hip and knee arthroplasty?","volume":"35","author":"Warren","year":"2020","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib2","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1007\/s00198-017-4213-y","article-title":"Excess risk of venous thromboembolism in hip fracture patients and the prognostic impact of comorbidity","volume":"28","author":"Pedersen","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ocl.2025.02.006_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.surg.2014.10.005","article-title":"Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study","volume":"157","author":"Cohoon","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.ocl.2025.02.006_bib4","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.arth.2021.01.080","article-title":"Current practice trends in primary hip and knee arthroplasties among members of the American Association of Hip and Knee Surgeons: an update during the COVID-19 pandemic","volume":"36","author":"Abdel","year":"2021","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2106\/JBJS.21.01531","article-title":"Recommendations from the ICM-VTE: general","volume":"104","year":"2022","journal-title":"J Bone Jt Surg"},{"key":"10.1016\/j.ocl.2025.02.006_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2106\/JBJS.21.01529","article-title":"Recommendations from the ICM-VTE: hip & knee","volume":"104","year":"2022","journal-title":"J Bone Jt Surg"},{"key":"10.1016\/j.ocl.2025.02.006_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arth.2015.04.048","article-title":"Direct costs of aspirin versus warfarin for venous thromboembolism prophylaxis after total knee or hip arthroplasty","volume":"30","author":"Gutowski","year":"2015","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib8","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1302\/0301-620X.99B11.BJJ-2017-0337.R2","article-title":"Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions","volume":"99-B","author":"Azboy","year":"2017","journal-title":"Bone Jt J"},{"key":"10.1016\/j.ocl.2025.02.006_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5435\/00124635-200903000-00007","article-title":"Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty","volume":"17","author":"Johanson","year":"2009","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.ocl.2025.02.006_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2106\/JBJS.16.01253","article-title":"Venous thromboembolism following hip and knee arthroplasty: the role of aspirin","volume":"99","author":"Parvizi","year":"2017","journal-title":"J Bone Jt Surg"},{"key":"10.1016\/j.ocl.2025.02.006_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2106\/JBJS.16.00147","article-title":"Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis","volume":"99","author":"Parvizi","year":"2017","journal-title":"J Bone Jt Surg"},{"key":"10.1016\/j.ocl.2025.02.006_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arth.2021.10.001","article-title":"Aspirin thromboprophylaxis is associated with less major bleeding events following total joint arthroplasty","volume":"37","author":"Shohat","year":"2022","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-158-11-201306040-00004","article-title":"Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial","volume":"158","author":"Anderson","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ocl.2025.02.006_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ocl.2025.02.006_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamasurg.2018.3858","article-title":"Association of aspirin with prevention of venous thromboembolism in patients after total knee arthroplasty compared with other anticoagulants: a noninferiority analysis","volume":"154","author":"Hood","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ocl.2025.02.006_bib16","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.arth.2021.01.025","article-title":"Non-inferiority of aspirin for venous thromboembolism prophylaxis after hip arthroplasty in a statewide registry","volume":"36","author":"Muscatelli","year":"2021","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib17","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11999-017-5394-6","article-title":"Venous thromboembolism prophylaxis after TKA: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?","volume":"475","author":"Bala","year":"2017","journal-title":"Clin Orthop"},{"key":"10.1016\/j.ocl.2025.02.006_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arth.2015.07.001","article-title":"Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection","volume":"30","author":"Huang","year":"2015","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11999.0000000000000041","article-title":"Mobile compression reduces bleeding-related readmissions and wound complications after THA and TKA","volume":"476","author":"Arsoy","year":"2018","journal-title":"Clin Orthop"},{"key":"10.1016\/j.ocl.2025.02.006_bib20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1177\/1076029618772337","article-title":"Comparison of postoperative bleeding in total hip and knee arthroplasty patients receiving rivaroxaban, enoxaparin, or aspirin for thromboprophylaxis","volume":"24","author":"Lindquist","year":"2018","journal-title":"Clin Appl Thromb"},{"key":"10.1016\/j.ocl.2025.02.006_bib21","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.arth.2015.06.045","article-title":"Thromboembolism prophylaxis in hip arthroplasty: routine and high risk patients","volume":"30","author":"Nam","year":"2015","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib22","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1016\/j.arth.2017.05.042","article-title":"Comparative effectiveness and safety of drug prophylaxis for prevention of venous thromboembolism after total knee arthroplasty","volume":"32","author":"Cafri","year":"2017","journal-title":"J Arthroplast"},{"issue":"9 Suppl","key":"10.1016\/j.ocl.2025.02.006_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arth.2016.02.074","article-title":"Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty","volume":"31","author":"Huang","year":"2016","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.ocl.2025.02.006_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10654-014-9971-7","article-title":"Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population","volume":"30","author":"Thorat","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ocl.2025.02.006_bib26","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1016\/j.arth.2021.01.069","article-title":"Aspirin is safe for venous thromboembolism prophylaxis for patients with a history of gastrointestinal issues","volume":"36","author":"Grosso","year":"2021","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2106\/JBJS.18.00143","article-title":"The use of aspirin for prophylaxis against venous thromboembolism decreases mortality following primary total joint arthroplasty","volume":"101","author":"Rondon","year":"2019","journal-title":"J Bone Jt Surg"},{"key":"10.1016\/j.ocl.2025.02.006_bib28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamaoncol.2015.6396","article-title":"Population-wide impact of long-term use of aspirin and the risk for cancer","volume":"2","author":"Cao","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ocl.2025.02.006_bib29","article-title":"Surgical site infections and other postoperative complications following prophylactic anticoagulation in total joint arthroplasty","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ocl.2025.02.006_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jgar.2017.03.012","article-title":"Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus","volume":"10","author":"Chan","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ocl.2025.02.006_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/biomedicines10020263","article-title":"Aspirin and infection: a narrative review","volume":"10","author":"Di Bella","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ocl.2025.02.006_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fmed.2019.00217","article-title":"Aspirin effect on Staphylococcus aureus-platelet interactions during infectious endocarditis","volume":"6","author":"Hannachi","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/j.ocl.2025.02.006_bib33","doi-asserted-by":"crossref","first-page":"S345","DOI":"10.1016\/j.arth.2023.02.041","article-title":"Aspirin thromboprophylaxis following primary total knee arthroplasty is associated with a lower rate of early prosthetic joint infection compared with other agents","volume":"38","author":"Anil","year":"2023","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib34","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.RVW.20.00021","article-title":"Comparison of surgical site infection risk between warfarin, LMWH, and aspirin for venous thromboprophylaxis in TKA or THA: a systematic review and meta-analysis","volume":"8","author":"Hughes","year":"2020","journal-title":"JBJS Rev"},{"key":"10.1016\/j.ocl.2025.02.006_bib35","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2106\/JBJS.20.01428","article-title":"Platelet deficiency represents a modifiable risk factor for periprosthetic joint infection in a preclinical mouse model","volume":"103","author":"Greig","year":"2021","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.ocl.2025.02.006_bib36","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.arth.2022.07.006","article-title":"Low-dose aspirin for venous thromboembolism prophylaxis is associated with lower rates of periprosthetic joint infection after total joint arthroplasty","volume":"37","author":"Najafi","year":"2022","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.arth.2020.12.021","article-title":"Low-dose aspirin administered for venous thromboembolism prophylaxis reduces the incidence of heterotopic ossification in total joint arthroplasty","volume":"36","author":"Van Nest","year":"2021","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.artd.2020.01.010","article-title":"Aspirin used for venous thromboembolism prophylaxis in total hip arthroplasty decreases heterotopic ossification","volume":"6","author":"Vaz","year":"2020","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.ocl.2025.02.006_bib39","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/ans.18447","article-title":"Role of aspirin in the prevention of heterotopic ossification following total hip replacement: a systematic review and meta-analysis","volume":"93","author":"Wang","year":"2023","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ocl.2025.02.006_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12650","article-title":"Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK\/STAT-3 signalling pathway","volume":"52","author":"Wang","year":"2019","journal-title":"Cell Prolif"},{"key":"10.1016\/j.ocl.2025.02.006_bib41","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.2106\/JBJS.17.01110","article-title":"Type of anticoagulant used after total knee arthroplasty affects the rate of knee manipulation for postoperative stiffness","volume":"100","author":"Kahlenberg","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.ocl.2025.02.006_bib42","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.arth.2022.01.008","article-title":"Aspirin administered for venous thromboembolism prophylaxis may protect against stiffness following total knee arthroplasty","volume":"37","author":"Shohat","year":"2022","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1742-7843.2007.00149.x","article-title":"Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process","volume":"102","author":"Vuolteenaho","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ocl.2025.02.006_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3710959","article-title":"A review on the relationship between aspirin and bone health","volume":"2017","author":"Chin","year":"2017","journal-title":"J Osteoporos"},{"key":"10.1016\/j.ocl.2025.02.006_bib45","article-title":"Aspirin effect on bone remodeling and skeletal regeneration: review article","volume":"76","author":"Fattahi","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ocl.2025.02.006_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10856-022-06697-w","article-title":"Aspirin\/PLGA coated 3D-printed Ti-6Al-4V alloy modulate macrophage polarization to enhance osteoblast differentiation and osseointegration","volume":"33","author":"You","year":"2022","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.ocl.2025.02.006_bib47","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/0885328219889630","article-title":"Local administration of aspirin improves osseointegration of hydroxyapatite-coated titanium implants in ovariectomized rats through activation of the Notch signaling pathway","volume":"34","author":"Tao","year":"2020","journal-title":"J Biomater Appl"},{"key":"10.1016\/j.ocl.2025.02.006_bib48","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1016\/j.arth.2019.07.013","article-title":"Aspirin thromboprophylaxis confers no increased risk for aseptic loosening following cementless primary hip arthroplasty","volume":"34","author":"Goswami","year":"2019","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib49","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ocl.2025.02.006_bib50","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.arth.2018.04.040","article-title":"Majority of total joint arthroplasties are subtherapeutic on warfarin at time of discharge: another reason to avoid warfarin as a venous thromboembolism prophylaxis?","volume":"33","author":"Rondon","year":"2018","journal-title":"J Arthroplast"},{"key":"10.1016\/j.ocl.2025.02.006_bib51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.artd.2018.07.006","article-title":"Aspirin: are patients actually taking it?-A quality assessment study","volume":"4","author":"Lewis","year":"2018","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.ocl.2025.02.006_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/NOR.0000000000000367","article-title":"Self-reported rates of adherence to aspirin prescribed as an antithrombotic therapy following postoperative total joint replacement","volume":"36","author":"Wittig-Wells","year":"2017","journal-title":"Orthop Nurs"},{"key":"10.1016\/j.ocl.2025.02.006_bib53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00590-020-02833-w","article-title":"No difference in patient compliance between full-strength versus low-dose aspirin for VTE prophylaxis following total hip and total knee replacement","volume":"31","author":"Hood","year":"2021","journal-title":"Eur J Orthop Surg Traumatol"}],"container-title":["Orthopedic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003058982500029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003058982500029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:33:15Z","timestamp":1762216395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003058982500029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S003058982500029X"],"URL":"https:\/\/doi.org\/10.1016\/j.ocl.2025.02.006","relation":{},"ISSN":["0030-5898"],"issn-type":[{"type":"print","value":"0030-5898"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin for Venous Thromboembolism Prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Orthopedic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ocl.2025.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}